Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based pharmaceutical company that focuses on biopharmaceutical production, services, trading, and research. The company operates in several key business segments and distributes its products globally. With a high risk rating ESG score of 36.0, Hepalink is a prominent player in the pharmaceutical industry, generating a significant portion of its revenue from the USA and Europe.